ITMCTR Will Comprehensively Accept Clinical Trial Registrations in the Field of Traditional Medicine

According to the official announcement on the Chinese Clinical Trial Registry (ChiCTR) website (https://www.chictr.org.cn/), starting from July 15, 2024, ChiCTR will no longer accept registrations for clinical trials in the field of traditional medicine, including Chinese medicine, acupuncture, tui-na (traditional Chinese massage), herbal medicine, Ayurveda, homeopathy, Unani medicine, complementary and alternative medicine, and others. ITMCTR will fully accept clinical trial registrations in these areas, offering high-quality services for traditional medicine clinical trial registration and retrieval.

In February 2023, ITMCTR was officially recognized by WHO as a primary registry. It is the first registry organization to be categorized by the thematic scope of clinical trials across countries and regions. ITMCTR currently has a national expert advisory committee, consisting of 16 experts from China, Brazil, Malaysia, South Korea, Italy, Pakistan, Germany, Switzerland, and Japan. This committee is responsible for advising the China Academy of Chinese Medical Sciences and the China Center for Evidence Based Traditional Chinese Medicine on major strategic developments, aiming to promote the registration of clinical trials (research) in the field of traditional medicine and strengthen accountability and transparency in clinical trials (research) and their results dissemination.

ITMCTR will uphold the principles of collaborating with experts, scholars, and academic organizations in the field, providing dedicated channels for the registration of traditional medicine clinical trials. The platform will establish standardized clinical research registration protocols, promote transparency in traditional medicine clinical research, support the high-quality production of evidence for traditional medicine, and work towards advancing the role of traditional medicine in serving global health. ITMCTR will continue to drive efforts to enhance the transparency of traditional medicine clinical trials and improve the quality of clinical evidence in traditional medicine.